News Archive

Fujifilm Provides Education Advancement Opportunities for Gastroenterologists and Endoscopists at Digestive Disease Week 2022

Fujifilm Showcases New Endoscopy Innovations for the Detection, Diagnosis, and Treatment of Diseases at Digestive Disease Week 2022

RAYUS Radiology Partners with Fujifilm and selects Synapse® Enterprise Information System for Its Growing National Network  

FUJIFILM VisualSonics Launches the New Multi-modal Vevo F2 Imaging Platform for Preclinical Ultrasound 

Fujifilm Selected as Platinum Partner of the National Rural Health Association

Fujifilm Awarded Pacific Air Force/Navy Order from the U.S. Department of Defense and Defense Logistics Agency for Synapse PACS

FUJIFILM Diosynth Biotechnologies Breaks Ground on Expansion of its 
BioProcess Innovation Center
 

Defense Logistics Agency Awards Fujifilm a Five-Year Contract to Provide Endoscopic Equipment, Technology and Training 

Fujifilm Installs Synapse 7x Cardiology PACS in Emory Healthcare Facilities 

Chimeron Bio Enters Into Manufacturing Agreement With FUJIFILM Diosynth Biotechnologies to Advance its RNA Oncology Candidates

Fujifilm Completes Acquisition of a Dedicated Cell Therapy Manufacturing Facility from Atara Biotherapeutics, Inc.

Fujifilm Completes Acquisition of Shenandoah Biotechnology 

Fujifilm to Acquire Shenandoah Biotechnology, 
Leading Manufacturer of Recombinant Proteins 
 

FUJIFILM Diosynth Biotechnologies Gifts $200,000 to Wake Tech Foundation to Establish Early College Suite
 

Fujifilm Presents Award-winning Synapse Enterprise Imaging Portfolio at HIMSS 2022

Promega Corporation and FUJIFILM Cellular Dynamics Announce Strategic Collaboration to Advance Novel Assay Development

FUJIFILM Sonosite Files Patent Infringement Lawsuit Against Butterfly Network

Gastro Care Partners Taps Fujifilm to Deliver Best in Breed Endoscopic Imaging Solutions to GI Practices in Colorado

FUJIFILM Sonosite launches Sonosite LX, the industry leader’s latest premium point-of-care ultrasound system

Fujifilm launches life sciences strategic investment fund focused on emerging companies with high impact biotechnology